OM3L:XETRA:XETRA-iShares MSCI USA ESG Enhanced UCITS ETF USD Inc (EUR)

ETF | Others |

Last Closing

USD 8.315

Change

+0.27 (+3.33)%

Market Cap

N/A

Volume

0.11M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.65 (+1.48%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

N/A

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.21 (+0.94%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.12 (+0.96%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.08 (+1.59%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.25 (+1.13%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.39 (+3.48%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.90 (-3.28%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.19 (+2.07%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.02 (+0.01%)

USD 12.26B

ETFs Containing OM3L:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.12% 12% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.12% 15% F 16% F
Trailing 12 Months  
Capital Gain -0.80% 35% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.80% 38% F 41% F
Trailing 5 Years  
Capital Gain 74.59% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.59% 73% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.76% 83% B 81% B-
Dividend Return 14.95% 83% B 80% B-
Total Return 0.19% 24% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 15.73% 30% F 43% F
Risk Adjusted Return 95.09% 82% B 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.